In the News

395 News Items found
Lucy Kalanithi gestures while speaking. Physicians in white lab coats look on.
Support
Read a Q & A with Lucy Kalanithi, the widow of Paul Kalanithi, who wrote When Breath Becomes Air.
Rob with his wife and daughter
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.
Dana Pe'er
Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Pictured: Johanna Joyce
In the Lab
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Attendees of the fifth annual MSK-CTONG Symposium
Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.
MSK physician-scientist Yu Chen
The findings could pave the way toward more targeted treatments for the disease.
Proximal tubule of the kidney.
In the Lab
Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.
A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
MSK surgeons are highly skilled at treating even the most difficult gynecologic cancers.
In the Clinic
Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.
Image of As, Ts, Cs, and Gs representing genetic code
Announcement
Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.